Literature DB >> 27620493

Galectin-3 binds highly galactosylated IgG1 and is crucial for the IgG1 complex mediated inhibition of C5aReceptor induced immune responses.

Kerstin A Heyl1, Christian M Karsten2, Hortense Slevogt3.   

Abstract

Changes in the glycosylation of immunoglobulins have been shown to modulate immune homeostasis and disease pathology. In this sense it has been shown that highly galactosylated but not agalactosylated IgG1 immune complexes (ICs) inhibit C5aR-mediated pro-inflammatory immune responses via the assembly of FcγRIIB-Dectin-1 receptor complexes. In this study we demonstrated that Galectin-3, a galactose-binding lectin that is known to cross-link proteins on cell-surfaces via binding their N-glycans, bound to highly-galactosylated, but not agalactosylated IgG1. Further, Galectin-3 was essential for the IC-mediated inhibition of C5a-induced neutrophil chemotaxis in vitro. Taken together our results indicate that Galectin-3 mediates the interaction of ICs with the FcγRIIB-Dectin-1 receptor complex for delivering immunoregulatory signals to inhibit C5aR-mediated immune responses.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fc FcγRIIB-Dectin-1 receptor complex; Galectin-3; IgG1 immune complexes; Neutrophil chemotaxis

Mesh:

Substances:

Year:  2016        PMID: 27620493     DOI: 10.1016/j.bbrc.2016.09.038

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

Review 1.  Breaking the Glyco-Code of HIV Persistence and Immunopathogenesis.

Authors:  Florent Colomb; Leila B Giron; Irena Trbojevic-Akmacic; Gordan Lauc; Mohamed Abdel-Mohsen
Journal:  Curr HIV/AIDS Rep       Date:  2019-04       Impact factor: 5.071

2.  Frontline Science: Plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy.

Authors:  Surya Kumari Vadrevu; Irena Trbojevic-Akmacic; Andrew V Kossenkov; Florent Colomb; Leila B Giron; Alitzel Anzurez; Kenneth Lynn; Karam Mounzer; Alan L Landay; Robert C Kaplan; Emmanouil Papasavvas; Luis J Montaner; Gordan Lauc; Mohamed Abdel-Mohsen
Journal:  J Leukoc Biol       Date:  2018-04-06       Impact factor: 4.962

Review 3.  Understudied Factors Influencing Fc-Mediated Immune Responses against Viral Infections.

Authors:  Sai Priya Anand; Andrés Finzi
Journal:  Vaccines (Basel)       Date:  2019-08-30

4.  Plasma and antibody glycomic biomarkers of time to HIV rebound and viral setpoint.

Authors:  Leila B Giron; Emmanouil Papasavvas; Livio Azzoni; Xiangfan Yin; Alitzel Anzurez; Mohammad Damra; Karam Mounzer; Jay R Kostman; Ian Sanne; Cynthia S Firnhaber; Hiroaki Tateno; Qin Liu; Luis J Montaner; Mohamed Abdel-Mohsen
Journal:  AIDS       Date:  2020-04-01       Impact factor: 4.632

5.  Potential of Murine IgG1 and Human IgG4 to Inhibit the Classical Complement and Fcγ Receptor Activation Pathways.

Authors:  Gina-Maria Lilienthal; Johann Rahmöller; Janina Petry; Yannic C Bartsch; Alexei Leliavski; Marc Ehlers
Journal:  Front Immunol       Date:  2018-05-09       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.